The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Cooperative Agreement to the University of Massachusetts Medical School for $399,303 on September 30, 2026, under the Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and P.R. program (CFDA 93.377).
The award funds the development and evaluation of computable phenotypes to identify active surveillance in prostate cancer using electronic health record data. Work is performed in Massachusetts with a period of performance through September 29, 2028. The five-year program supports public health efforts to reduce disability and death from chronic disease in American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, U.S. Virgin Islands, and Puerto Rico, implementing evidence-based strategies adapted to cultural and geographic contexts including tobacco use reduction, diabetes and cardiovascular disease prevention and management, and improved data availability to inform chronic disease programs.
Generated 9/8/26, 6:04 AM